← Back
▼ SELL 10b5-1 Plan

$ Value

$944K

Shares

6,203

Price

$152

Filed

Apr 30

Insider

Name

Chapman Steven Leonard

Title

CEO AND PRESIDENT

CIK

0001711968

Roles

Director Officer

Transaction Details

Transaction Date

2025-04-28

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

192,162

Footnotes

The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 27, 2023 and January 26, 2024.

Filing Info

Accession No.

0001415889-25-011610

Form Type

4

Issuer CIK

0001604821

Chapman Steven Leonard's History

Date Ticker Type Value
2026-03-10 NTRA $1.1M
2026-03-09 NTRA A
2026-03-02 NTRA $223K
2026-03-02 NTRA $493K
2026-03-02 NTRA $73K
2026-02-27 NTRA A
2026-02-03 NTRA $1.1M
2026-02-02 NTRA $1.5M
2026-02-02 NTRA $9.6M
2026-02-02 NTRA $4.6M

Other Insiders at NTRA (90d)

Insider Bought Sold Last
BOTHA ROELOF 2026-01-30
ROSENMAN HERM 2026-01-30
Williams Brinkley Ruth 2026-01-30
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
$38.3M 2026-04-06
Sheena Jonathan $2.4M 2026-04-17
Baynes Roy D. 2026-01-30
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
$2.9M 2026-03-10
Marcus Gail Boxer 2026-01-30
Chapman Steven Leonard
CEO AND PRESIDENT
$24.1M 2026-03-10
Bertagnolli Monica 2026-01-30
Chapman Rowan E $23K 2026-03-13
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
$4.5M 2026-04-01
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
$3.0M 2026-04-01
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
$1.4M 2026-03-10